BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12832416)

  • 1. Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.
    Holzberg D; Knight CG; Dittrich-Breiholz O; Schneider H; Dörrie A; Hoffmann E; Resch K; Kracht M
    J Biol Chem; 2003 Oct; 278(41):40213-23. PubMed ID: 12832416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway.
    Hoffmann E; Ashouri J; Wolter S; Doerrie A; Dittrich-Breiholz O; Schneider H; Wagner EF; Troppmair J; Mackman N; Kracht M
    J Biol Chem; 2008 May; 283(18):12120-8. PubMed ID: 18281687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK-dependent phosphorylation of c-Jun on serine 63 mediates nitric oxide-induced apoptosis of neuroblastoma cells.
    Li L; Feng Z; Porter AG
    J Biol Chem; 2004 Feb; 279(6):4058-65. PubMed ID: 14617628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
    Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
    J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
    Kieser A; Kilger E; Gires O; Ueffing M; Kolch W; Hammerschmidt W
    EMBO J; 1997 Nov; 16(21):6478-85. PubMed ID: 9351829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling.
    Chandrasekar B; Mummidi S; Valente AJ; Patel DN; Bailey SR; Freeman GL; Hatano M; Tokuhisa T; Jensen LE
    J Biol Chem; 2005 Jul; 280(28):26263-77. PubMed ID: 15890643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
    Ishikawa Y; Kitamura M
    Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of C-jun N-terminal kinase and AP-1 activation.
    Liao HL; Zhu Y; Wang N; Verna L; Stemerman MB
    Endothelium; 2000; 7(2):121-33. PubMed ID: 10865940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
    Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
    J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
    Adler V; Pincus MR
    Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK-independent activation of c-Jun during neuronal apoptosis induced by multiple DNA-damaging agents.
    Besirli CG; Johnson EM
    J Biol Chem; 2003 Jun; 278(25):22357-66. PubMed ID: 12684520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
    Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
    Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A; Black EJ; Unlu M; Gillespie DA
    Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK.
    Naumann M; Bech-Otschir D; Huang X; Ferrell K; Dubiel W
    J Biol Chem; 1999 Dec; 274(50):35297-300. PubMed ID: 10585392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells.
    Ammendrup A; Maillard A; Nielsen K; Aabenhus Andersen N; Serup P; Dragsbaek Madsen O; Mandrup-Poulsen T; Bonny C
    Diabetes; 2000 Sep; 49(9):1468-76. PubMed ID: 10969830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
    Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
    Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells.
    Schmeck B; Moog K; Zahlten J; van Laak V; N'Guessan PD; Opitz B; Rosseau S; Suttorp N; Hippenstiel S
    Respir Res; 2006 Jul; 7(1):98. PubMed ID: 16834785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.
    Chen CC; Chow MP; Huang WC; Lin YC; Chang YJ
    Mol Pharmacol; 2004 Sep; 66(3):683-93. PubMed ID: 15322261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.
    Bonny C; Oberson A; Negri S; Sauser C; Schorderet DF
    Diabetes; 2001 Jan; 50(1):77-82. PubMed ID: 11147798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.